临床肺科杂志
臨床肺科雜誌
림상폐과잡지
JOUNAL OF CLINICAL PULMONARY MEDICINE
2014年
7期
1267-1269
,共3页
结核分枝杆菌%药敏试验%耐多药结核
結覈分枝桿菌%藥敏試驗%耐多藥結覈
결핵분지간균%약민시험%내다약결핵
mycobacterium tuberculosis%susceptibility test%multidrug resistant tuberculosis
目的:了解南京地区胸科医院结核病患者结核分枝杆菌对临床常用9种药物的耐药情况。方法对我院分离的结核分枝杆菌采用绝对浓度法对9种抗结核药物:链霉素、异烟肼、乙胺丁醇、利福平、对氨基水杨酸、丁胺卡那霉素、卷曲霉素、左氧氟沙星、对氨基水杨酸异烟肼进行药敏试验,同时用PNB、TCH进行菌种初步鉴定。结果10014株结核分枝杆菌中,总耐药率38.42%(3847/10014),单耐药率最高为利福平(27.35%),最低为卷曲霉素(0.50%);2017株耐多药结核分枝杆菌对另外7种药物单耐药率最高为链霉素(56.22%),最低为卷曲霉素(1.69%),对9种药物全耐者有3株。结论结核分枝杆菌对多种药物耐药率高,应加强抗结核药物耐药性监测,根据药敏试验结果选择科学有效的化疗方案。
目的:瞭解南京地區胸科醫院結覈病患者結覈分枝桿菌對臨床常用9種藥物的耐藥情況。方法對我院分離的結覈分枝桿菌採用絕對濃度法對9種抗結覈藥物:鏈黴素、異煙肼、乙胺丁醇、利福平、對氨基水楊痠、丁胺卡那黴素、捲麯黴素、左氧氟沙星、對氨基水楊痠異煙肼進行藥敏試驗,同時用PNB、TCH進行菌種初步鑒定。結果10014株結覈分枝桿菌中,總耐藥率38.42%(3847/10014),單耐藥率最高為利福平(27.35%),最低為捲麯黴素(0.50%);2017株耐多藥結覈分枝桿菌對另外7種藥物單耐藥率最高為鏈黴素(56.22%),最低為捲麯黴素(1.69%),對9種藥物全耐者有3株。結論結覈分枝桿菌對多種藥物耐藥率高,應加彊抗結覈藥物耐藥性鑑測,根據藥敏試驗結果選擇科學有效的化療方案。
목적:료해남경지구흉과의원결핵병환자결핵분지간균대림상상용9충약물적내약정황。방법대아원분리적결핵분지간균채용절대농도법대9충항결핵약물:련매소、이연정、을알정순、리복평、대안기수양산、정알잡나매소、권곡매소、좌양불사성、대안기수양산이연정진행약민시험,동시용PNB、TCH진행균충초보감정。결과10014주결핵분지간균중,총내약솔38.42%(3847/10014),단내약솔최고위리복평(27.35%),최저위권곡매소(0.50%);2017주내다약결핵분지간균대령외7충약물단내약솔최고위련매소(56.22%),최저위권곡매소(1.69%),대9충약물전내자유3주。결론결핵분지간균대다충약물내약솔고,응가강항결핵약물내약성감측,근거약민시험결과선택과학유효적화료방안。
Objective To analyze the drug resistance of mycobacterium tuberculosis ( MTB) for 9 type anti-tuberculosis drugs in Nanjing chest Hospital. Methods MTB strains were tested with absolute concentration method for 9 type anti-tuberculosis drugs, including SM, INH, EMB, RFP, PAS, AMK, CPM, LVFX and PSNZ. Results The total ratio of drug resistance for 9 type anti-tuberculosis drugs was 38. 42% (3847/10014). The highest re-sistant rate was RFP (27. 35%), and the lowest was CPM (0. 50%). Of 2017 strains multidrug resistant tuberculo-sis (MDR-TB), the highest resistant rate was SM (56. 22%), and the lowest was CPM (1. 69%). There were 3 strains of MDR-TB resistant to another 7 type anti-tuberculosis drugs. Conclusion MTB is highly resistant to a vari-ety of antibiotics. Monitoring of resistance to anti-tuberculosis drugs must be strengthened.